Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute Myeloid Leukemia”
SGI-110 in Adults With Untreated Acute Myeloid Leukemia (AML), Not Considered Candidates for Intensive Remission Induction
ClinicalTrials.gov study NCT02348489. IPD Sharing: Not stated. Countries: 24. Publications: 1.
A Study of ASP2215 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase (FLT3) Mutation
ClinicalTrials.gov study NCT02421939. IPD Sharing: YES. Countries: 14. Publications: 4.
An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation
ClinicalTrials.gov study NCT02577406. IPD Sharing: Not stated. Countries: 18. Publications: 1.
Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant
ClinicalTrials.gov study NCT01252667. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01074047. IPD Sharing: Not stated. Countries: 18. Publications: 2.
Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00469014. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for In
ClinicalTrials.gov study NCT02472145. IPD Sharing: Not stated. Countries: 14. Publications: 1.
A Study of Oral Venetoclax Tablets and Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy
ClinicalTrials.gov study NCT04102020. IPD Sharing: YES. Countries: 19. Publications: 2.
Tagraxofusp in Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02113982. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study of Lenalidomide in Pediatric Subjects With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02538965. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Oxidative Phosphorylation Inhibitor IACS-010759 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02882321. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemotherapy for Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01307579. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Vorinostat in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00305773. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma
ClinicalTrials.gov study NCT04097301. IPD Sharing: Not stated. Countries: 2. Publications: 1.
PXD101 in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00357032. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00372593. IPD Sharing: Not stated. Countries: 6. Publications: 11.
Phase 1-2 of Azacitidine + Lenalidomide for Previously Untreated Elderly Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00890929. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Clofarabine vs Clofarabine in Plus With Low-Dose Ara-C in Previously Untreated Patients With Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndromes (MDS).
ClinicalTrials.gov study NCT00088218. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Safety and Tolerability Study of Crenolanib in Combination With Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia Patients With FLT3 Mutations
ClinicalTrials.gov study NCT02283177. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MS) With FLT3-ITD Mutation
ClinicalTrials.gov study NCT02196857. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.